Twist Bioscience Corporation TWST Reportable Segment — Operating Income (Loss)
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Twist Bioscience Corporation in its filing.
Tagged under the XBRL concept us-gaap:OperatingIncomeLoss.
The official record: Twist Bioscience Corporation’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →
Ask your AI about Twist Bioscience Corporation's reportable segment — operating income (loss).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Twist Bioscience Corporation's reportable segment — operating income (loss)?
- Twist Bioscience Corporation (TWST) reported reportable segment — operating income (loss) of -$45.86M in Q1 2026.
- How has Twist Bioscience Corporation's reportable segment — operating income (loss) changed year-over-year?
- Twist Bioscience Corporation's reportable segment — operating income (loss) decreased by 10.4% year-over-year, from -$41.56M to -$45.86M.
- What does reportable segment — operating income (loss) mean?
- Calculated as the segment's revenue minus its total operating costs and expenses, representing the core profitability of the segment before interest and taxes. It serves as the primary benchmark for the segment's operational performance and financial health.